Switch from Abiraterone + Prednisone to Abiraterone + Dexamethasone at asymptomatic PSA progression in metastatic castration ‐resistant prostate cancer (mCRPC) patients

BJU International,Volume 0, Issue ja, -Not available-.

Source: BJU International - August 12, 2018 Category: Urology & Nephrology Authors: Charlotte Fenioux , Christophe Louvet , Emilie Charton , Francois Rozet , Stanislas Ropert , Dominique Prapotnich , Eric Barret , Rafael Sanchez ‐Salas , Annick Mombet , Nathalie Cathala , Marie‐Liesse Joulia , Jean‐Luc Molit Source Type: research